DNA origami microarray biochip based on plasmon surface lattice resonance

Through DNA origami self-assembly technology and nanosphere etching technology, a high-precision DNA origami microarray biochip is constructed, which solves the problems of unstable detection efficiency and insufficient accuracy in the existing technology, and achieves high sensitivity and personalized customization. Label-free detection improves the detection accuracy and sensitivity of biochips.

CN119086503AActive Publication Date: 2024-12-06TIANFU JIANGXI LAB
View PDF 8 Cites 0 Cited by

Patent Information

Application Number
CN202411190058.7
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-08-28
Publication Date
2024-12-06
Estimated Expiration
2044-08-28

AI Technical Summary

Technical Problem

The existing labelless detection biochip based on plasmon surface lattice resonance has problems such as unstable detection efficiency, low device consistency and standardization, and the plasmon nanostructure accuracy is usually 50 nm or above, which is limited. The dynamic detection range of light sensing.

Method used

DNA origami self-assembly technology is used to construct DNA origami microarray biochip, and a periodic patterned SiO2 substrate is formed through nanosphere etching technology. Combined with DNA origami and plasmon nanostructures and biomolecular probes, the assembly of 10 nm The following accuracy of the plasmon nanostructure-biomolecular probe units cross-scale processing improves detection accuracy and sensitivity.

Benefits of technology

Realize low-cost, high-precision, high sensitivity, and personalized and customized label-free detection biochip, improves biochemical characteristics, meets personalized medical needs, and can integrate more than one million in a highly orderly manner within the millimeter level. The molecular probe realizes ultra-low concentration detection.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN119086503A_ABST
    Figure CN119086503A_ABST
Patent Text Reader

Abstract

The invention relates to the technical field of biochips, and provides a DNA origami microarray biochip based on plasmon surface lattice resonance, which comprises a chip substrate and DNA origami-plasmon nanostructure-biomolecule probe units arranged in an array, the preparation method comprises the following steps: stretching out the a-type single chain for grabbing and connecting the plasmon nanoparticles and the biomolecular probe from the surface of the DNA origami; then, plasmon nanoparticles and biomolecular probes are modified with b-type single-stranded DNA complementarily paired with a-type single-stranded bases; constructing hydrophilic array-arranged point locations on the surface of the substrate; each point location is connected with DNA origami to form a microarray; the method comprises the following steps: assembling a biomolecular probe and plasmon nanoparticles on DNA origami through base complementary pairing to form a plasmon-biomolecular probe microarray; according to the biochip, personalized customization aiming at detection of multiple or one pathogen can be realized, and the manufacturing method is economical and efficient and can meet personalized medical requirements.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention relates to the technical field of biochips, and in particular to a DNA origami microarray biochip based on plasmon surface lattice resonance and a preparation method and application thereof. Background Art

[0002] Biochip is a technology that achieves high-throughput biomolecule detection and analysis by fixing a large number of molecular probes on a small solid substrate. It is used in the fields of drug action research, infectious disease detection, cancer diagnosis, drug screening, food safety monitoring, etc. Optical sensing biochips designed with optical sensing mechanisms such as surface plasmon resonance (SPR) and fluorescence resonance energy transfer (FRET) can respond quickly and monitor in real time. Among them, SPR-based optical sensing can achieve label-free detection, that is, there is no need to fluorescently or radioactively label biomolecules, which reduces sample preparation steps, reduces costs, and avoids changes in the structure and function of biomolecules caused by labels. Therefore, the role of SPR in label-free biological detection has attracted great attention in recent years.

[0003] The SPR effect is an important optical property of plasmon nanomaterials. The principle of label-free detection based on SPR is that when the light source and the plasmon nanomaterial on the chip undergo surface plasmon resonance, a strong resonance peak will be generated in the extinction spectrum. When biological molecules interact with molecules near plasmon nanomaterials (such as antibodies and antigens), the SPR characteristics change, and the plasmon resonance wavelength and phase will shift.

[0004] When plasmon nanostructures are arranged in an array at micro-nanoscale spacing, their arrangement forms a lattice-like structure, and the plasmon surface lattice resonance effect (SLR) occurs. Compared with the SPR effect, SLR produces a plasmon resonance peak with a very narrow bandwidth (2 nm). Due to the narrowband characteristics of SLR, it has a higher sensitivity to the detection of surrounding molecular interactions.

[0005] Existing label-free detection biochips based on the SLR effect are mainly based on simple plasmon nanoparticle arrays. The connected and adsorbed biomolecular probes are usually randomly distributed, and have shortcomings such as unstable detection efficiency, low device consistency and standardization. In addition, the accuracy of plasmon nanostructures is usually 50 nm or above, which limits the dynamic detection range of optical sensing. Summary of the invention

[0006] In order to realize the preparation of low-cost, high-precision, high-sensitivity, and customizable label-free detection biochips, the purpose of the present invention is to provide a DNA origami microarray biochip based on plasmon surface lattice resonance and its preparation method, which is based on DNA origami microarrays and proposes a cross-scale processing from the core unit of the "DNA origami-plasmon nanostructure-biomolecular probe" assembly with an accuracy of less than 10 nm to a micrometer-level array. Based on the SLR effect of the plasmon nanoarray and the interaction between the integrated biomolecular probe (such as a specific antibody) and the target detection object, real-time label-free and high-sensitivity detection is achieved.

[0007] Compared with the existing technology, the DNA origami self-assembly technology is used to construct DNA origami microarray biochips, which can form plasmonic nanostructures-biomolecular probe units with a precision of less than 10 nm through self-assembly, and a variety of biomolecular probes (such as various specific antibodies) can be customized on each array unit. This high-precision DNA origami microarray biochip manufacturing method is economical and efficient, improves the biochemical properties of label-free detection biochips, and can meet personalized medical needs.

[0008] The embodiments of the present invention are implemented by the following technical solutions:

[0009] A DNA origami microarray biochip based on plasmon surface lattice resonance, the overall structure of which includes two parts: a chip substrate and arrayed DNA origami-plasmon nanostructure-biomolecule probe units, the chip substrate is made of SiO2 with a refractive index between 1.45 and 1.5.

[0010] Furthermore, the chip substrate is periodically patterned using nanosphere etching technology, with a period of 100-1000 nm and a period number of the order of 100-10000, arranged in one of a hexagonal array and a square array.

[0011] Furthermore, the DNA origami is folded by a long DNA single strand (such as a long scaffolding strand, such as an M13mp18 phage single strand) and several short DNA single strands (such as staple short strands) through base complementary pairing; its shape is one of a triangle, a quadrilateral, a hexagon, an octagon or a circle; the size of the DNA origami is between 50-300 nm.

[0012] Furthermore, the plasmon nanostructure is a single plasmon nanoparticle and / or a plurality of plasmon nanoparticles.

[0013] Furthermore, the plasmon nanoparticles are one of metal nanoparticles, hybrid metal nanoparticles, and hybrid metal-medium nanoparticles, and their shapes are one of spheres, rods, cubes, stars, disks, and core-shell spherical structures.

[0014] A method for preparing a DNA origami microarray biochip based on plasmon surface lattice resonance comprises the following steps:

[0015] Step 1: Design DNA origami with a type-a single strand extending from its surface for grabbing and connecting one or more plasmonic nanoparticles and biomolecular probes;

[0016] Step 2: modifying plasmonic nanoparticles and biomolecular probes with type b single-stranded DNA that is complementary to type a single-stranded base pairing;

[0017] Step 3: The substrate is patterned by nanosphere etching technology and surface oxygen plasma treatment to form points arranged in a hydrophilic array;

[0018] Step 4: DNA origami is connected to each spot to form a microarray; specifically, the spots are connected by Mg 2+ Connecting DNA origami with hydroxyl groups to form DNA origami arrays;

[0019] Step 5: Through complementary base pairing, the self-assembled biomolecular probes and plasmon nanoparticles are precisely and controllably positioned on the DNA origami to form a plasmon-biomolecular probe microarray, wherein both the biomolecular probes and plasmon nanoparticles can be of multiple types and combined into units in a designed manner.

[0020] More specifically, the preparation method is as follows:

[0021] S1. Mix the long sequence DNA single strand (scaffold strand, such as M13mp18 phage single strand) with the short DNA single strand (staple strand), plasmon nanoparticle grab strand, and biomolecule grab strand in a molar ratio of 1:15-25:15-25:15-25, heat to 70-90℃ in a nucleic acid amplification instrument, keep for 5-10 minutes, then anneal from 75℃ to 25-30℃, and finally purify by gel electrophoresis, the buffer is 0.5×TAE-Mg 2+ ;

[0022] S2. Using a SiO2 substrate, treated with O2 plasma, nanospheres (such as polystyrene spheres) with a diameter of 500 nm are deposited on the substrate to form hexagonal close-packed single-layer / multi-layer nanospheres; then treated with hexamethyldisilazane (HMDS) solution in a vacuum dryer to add hydrophobic trimethylsilyl groups on the surface of the substrate; finally, the substrate sheet is ultrasonically treated in water to remove the nanospheres on the surface, and then treated with O2 plasma to generate hydrophilic silanol groups on the circular array sites; DNA origami solution is dropped on the etched array, incubated in a moist container for one hour to connect the DNA origami to the hydrophilic sites, and then washed multiple times with a 0.07% Tween-20 buffer (Tris, MgCl2) to remove excess DNA origami;

[0023] S3. Plasmonic nanoparticles (such as gold nanospheres / gold nanorods) and biomolecular probes (such as specific IgG antibodies) are modified with thiol single-stranded DNA (such as PolyT, CT-9, etc.), and purified by gel electrophoresis, with the electrophoresis buffer being 0.5×TBE; the modified plasmonic nanoparticle solution is added to the buffer on the surface of the above substrate, the temperature is controlled under wet conditions, and after annealing and incubation overnight, the substrate surface is washed with a buffer containing MgCl2 to remove excess plasmonic nanoparticles; the modified biomolecular probe (such as specific IgG antibody) solution is then added to the buffer on the surface of the substrate, incubated at 37°C for more than 1 hour, and the substrate surface is rinsed with the buffer; since the grabbing chains of nanoparticles and biomolecules are pre-designed at specific positions on the DNA origami surface, the plasmonic nanoparticles and biomolecules modified with complementary single-stranded DNA will be effectively connected to specific sites on the DNA origami through base complementary pairing, thus forming a "DNA origami-plasmonic nanostructure-biomolecular probe" composite structural unit.

[0024] In another aspect, the present invention also provides an application of the above biochip in biomolecule detection; specifically, the light emitted by the light source penetrates the blood droplet and the biochip, and the biomolecule detection data can be directly obtained according to the spectrum and resonance peak shift analysis of the photodetector transmission and the PC end. Multiple resonance peak shifts can be used as a basis for judging biomolecule detection.

[0025] The technical solution of the embodiment of the present invention has at least the following advantages and beneficial effects:

[0026] 1. The present invention uses DNA origami self-assembly technology to construct microarray units and biomolecular probes, so that the biochip can be customized for multiple or one pathogen detection.

[0027] 2. The present invention manufactures arrayed patterns by etching nanospheres, and further realizes plasmon-bioprobe microarrays, which has low cost, high scalability, and high device consistency and standardization of the chip.

[0028] 3. The biological probe of the present invention has a high degree of integration, and more than a million molecular probes are highly and orderly integrated within the millimeter range. Only 50 μL of blood sample is needed to detect the target object.

[0029] 4. The present invention is based on the SLR effect, has a high Q value optical sensing signal, and can realize ultra-low concentration detection. BRIEF DESCRIPTION OF THE DRAWINGS

[0030] In order to more clearly illustrate the technical solutions of the embodiments of the present invention, the drawings required for use in the embodiments are briefly introduced below. It should be understood that the following drawings only show certain embodiments of the present invention and therefore should not be regarded as limiting the scope. For ordinary technicians in this field, other related drawings can be obtained based on these drawings without creative work.

[0031] Figure 1 A schematic diagram of a DNA origami microarray biochip and a "DNA origami-plasmon nanostructure-biomolecular probe" unit provided in Example 1 of the present invention;

[0032] Figure 2 A schematic diagram of realizing a DNA origami array by etching a substrate using polystyrene balls provided in Example 1 of the present invention;

[0033] Figure 3 A schematic diagram of the biochip provided in Example 1 of the present invention for detecting biomolecules based on the SLR effect;

[0034] Figure 4 The simulated light transmittance of the plasmon nanostructure array used in Example 1 of the present invention. DETAILED DESCRIPTION

[0035] In order to make the purpose, technical scheme and advantages of the embodiments of the present invention clearer, the technical scheme in the embodiments of the present invention will be described clearly and completely below. If the specific conditions are not specified in the embodiments, they are carried out according to conventional conditions or conditions recommended by the manufacturer. If the manufacturer of the reagents or instruments used is not specified, they are all conventional products that can be purchased commercially.

[0036] Example 1

[0037] This embodiment provides a DNA origami microarray biochip based on plasmon surface lattice resonance, such as Figure 1 As shown, Figure 1The basic structure of the biochip of the present invention is shown. This embodiment uses hexagonal DNA origami with a diameter of about 240 nm to construct two C6 rotationally symmetric plasmon nanostructure units, one of which is a chiral assembly such as Figure 1 (1) shows that one is a non-chiral assembly such as Figure 1 (2) and connected to specific IgG antibodies in the gap.

[0038] The method for preparing the biochip of this embodiment comprises the following steps:

[0039] S1. The M13mp18 phage single strand was mixed with the designed staple short strand, plasmon nanoparticle grab strand, and biomolecule grab strand at a molar ratio of 1:20:20:20, heated to 80°C in a nucleic acid amplifier for 5 minutes, then annealed from 75°C to 27°C, and finally purified by gel electrophoresis in a 0.5×TAE-Mg buffer. 2+ .

[0040] S2. Figure 2 The present invention demonstrates the process of etching a substrate using polystyrene balls (PS balls) and connecting DNA origami. A SiO2 substrate is used, treated with O2 plasma, and PS balls with a diameter of 500 nm are deposited on the substrate to form hexagonal close-packed single-layer / multilayer nanospheres. Then, it is treated with hexamethyldisilazane (HMDS) solution in a vacuum dryer to add hydrophobic trimethylsilyl groups on the surface of the substrate. Finally, the PS balls on the surface are removed by ultrasonic treatment of the substrate in water, and then hydrophilic silanol groups are generated on the circular array sites by O2 plasma treatment. The DNA origami solution is dropped on the etched array, incubated in a wet container for one hour, so that the DNA origami is connected to the hydrophilic site, and then washed 5 times with a 0.07% Tween-20 buffer (Tris, MgCl2) to remove excess DNA origami. After this step, the DNA origami array can be characterized by AFM.

[0041] S3. Gold nanospheres / gold nanorods and specific IgG antibodies are modified with thiol single-stranded DNA (such as PolyT, CT-9, etc.), and purified by gel electrophoresis, with a buffer of 0.5×TBE. The modified plasmon nanoparticle solution is added to the buffer on the surface of the substrate, the temperature is controlled under wet conditions, and after annealing and incubation overnight, the substrate surface is washed with a buffer containing MgCl2 to remove excess plasmon nanoparticles. The modified IgG antibody solution is then added to the buffer on the surface of the substrate, incubated at 37°C for more than 1 hour, and the substrate surface is rinsed with a buffer to form an arrayed DNA origami-plasmon nanostructure-biomolecular probe composite structural unit on the substrate surface; the biochip is obtained.

[0042] Experimental example

[0043] This experimental example provides a schematic diagram of the principle of biochip prepared in the embodiment for biomolecule detection based on SLR effect; see Figure 3 ,Depend on Figure 3 It can be seen that when specific antibody molecules near the surface of plasmon nanoparticles bind to antigens in the test blood and cause a change in the refractive index, the plasmon resonance wavelength will shift.

[0044] Figure 4 The resonance peak spectra of SPR and SLR generated by the present invention are shown. Since the plasmon nanostructure includes two types of nanoparticles, spherical and rod-shaped, there are two SPR resonance peaks, and two SLR resonance peaks are generated at the same time. Based on the narrow resonance band of SLR, the detection limit and sensitivity can be greatly improved. The light emitted by the light source penetrates the blood droplets and the biochip, and the biomolecule detection data can be directly obtained based on the transmission of the photodetector and the spectrum and resonance peak shift analysis of the PC end. Multiple resonance peak shifts can be used in conjunction as a basis for judging biomolecule detection.

[0045] The above embodiment is only one of the implementation methods of the present invention. The DNA origami used includes but is not limited to four types: triangle, quadrilateral, octagon, and circle. The prepared plasmonic nanostructures include but are not limited to chiral and achiral arrangement assemblies formed by six types of nanoparticles: spherical, rod-shaped, cubic, star-shaped, disk-shaped, and core-shell spherical structures. Any modifications made to the main design of the present invention that have no substantive significance, as long as the technical problems they solve are still consistent with the present invention, should be included in the scope of protection of the present invention.

Claims

1. A DNA origami microarray biochip based on plasmon surface lattice resonance, characterized in that: include: DNA origami and plasmonic nanostructures arranged on substrates and arrays - biomolecular probe units; The substrate surface has a plurality of points arranged in a hydrophilic array, and DNA origami with hydroxyl groups are connected to the points to form a DNA origami array; The plasmon nanostructure and the biomolecule probe are modified by thiol-single-stranded DNA and connected to the DNA origami according to the principle of complementary base pairing.

2. The DNA origami microarray biochip based on plasmon surface lattice resonance according to claim 1, characterized in that: The substrate is periodically patterned by using nanosphere etching technology, with a period of 100-1000 nm and a period number of 100-10000, arranged in one of a hexagonal array and a square array.

3. The DNA origami microarray biochip based on plasmon surface lattice resonance according to claim 2, characterized in that: The substrate is made of SiO2, and its refractive index is between 1.45 and 1.

5.

4. The DNA origami microarray biochip based on plasmon surface lattice resonance according to claim 1, characterized in that: The DNA origami is formed by folding a long DNA single strand and several short DNA single strands through base complementary pairing; its shape is one of a triangle, a quadrilateral, a hexagon, an octagon or a circle; and the size of the DNA origami is between 50-300 nm.

5. The DNA origami microarray biochip based on plasmon surface lattice resonance according to claim 1, characterized in that: The plasmon nanostructure is a single plasmon nanoparticle and / or a plurality of plasmon nanoparticles.

6. The DNA origami microarray biochip based on plasmon surface lattice resonance according to claim 5, characterized in that: The plasmon nanoparticles are one of metal nanoparticles, hybrid metal nanoparticles, and hybrid metal-medium nanoparticles, and their shapes are one of spheres, rods, cubes, stars, disks, and core-shell spherical structures.

7. A method for preparing a DNA origami microarray biochip based on plasmon surface lattice resonance according to any one of claims 1 to 6, characterized in that: The following steps are involved: S1. Mix the long DNA single strand with the short DNA single strand, the plasmon nanoparticle grabbing strand, and the biomolecule probe grabbing strand, heat them in a nucleic acid amplifier for a period of time, anneal them, and then purify them; S2. The substrate surface is deposited with nanospheres by nanosphere etching technology, and then the substrate surface is treated hydrophobically to cause the nanospheres on the surface to fall off, forming circular array sites; the surface is treated with oxygen plasma to generate hydrophilic sites on the circular array sites; a DNA origami solution is dropped onto the etched hydrophilic sites, incubated for a period of time to allow the DNA origami to connect to the hydrophilic sites, and then washed with a buffer solution to form a DNA origami array; S3. Plasmonic nanoparticles and biomolecular probes are modified with thiolated single-stranded DNA, and the modified plasmonic nanoparticle solution is added to the buffer solution on the substrate surface in S2, and the temperature is controlled under wet conditions. After annealing and incubation overnight, the substrate surface is washed with a buffer solution containing magnesium ions; the modified biomolecular probe solution is then added to the buffer solution on the substrate surface, incubated for a period of time, and the substrate surface is washed with the buffer solution for a period of time, so that arrayed DNA origami-plasmonic nanostructure-biomolecular probe composite structural units are formed on the substrate surface; and the biochip is obtained.

8. The method for preparing a DNA origami microarray biochip based on plasmon surface lattice resonance according to claim 7, characterized in that: In S1, the long DNA single strand, the short DNA single strand, the plasmon nanoparticle grabbing strand, and the biomolecule probe grabbing strand are mixed in a molar ratio of 1:15-25:15-25:15-25.

9. The method for preparing a DNA origami microarray biochip based on plasmon surface lattice resonance according to claim 7, characterized in that: When the substrate surface is subjected to hydrophobic treatment, it is treated with a hexamethyldisilazane solution to add hydrophobic trimethylsilyl groups to the substrate surface.

10. Use of the DNA origami microarray biochip based on plasmon surface lattice resonance according to any one of claims 1 to 6 or the biochip prepared by the preparation method according to any one of claims 7 to 9 in biomolecule detection.

Citation Information

Patent Citations

  • Fluorescence enhanced microarray biochip based on micro / nano periodic structures and method for preparing same

    CN102901715A

  • Three-dimensional carrier of microarray biochip and preparation method thereof

    CN103147133A

  • DNA sequencing by synthesis with nucleotide analogues and raman detection

    CN109562142A

  • Surface plasmon enhanced signal probe constructed based on DNA origami nano-assembly and preparation method and application of surface plasmon enhanced signal probe

    CN114544584A

  • Comparing the peptide, antibody or nucleic acid profiles of two cell extract samples comprises using a mixed nucleotide / peptide microarray biochip involving defined amino acid and nucleotide sequences

    FR2928737A1